COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,357 Articles (22,803 medRxiv, 8,554 bioRxiv)

Most recent first Previous |  Page 1652: Articles 16511-16520  | Next

Modelling, Simulations and Analysis ofthe First and Second COVID-19 Epidemics in Beijing
Min, L.
10.1101/2021.04.02.21254821 — Posted: 2021-04-07
The statistical analysis of daily data associated with different parameters of the New Coronavirus COVID-19 pandemic in Georgia and their short-term interval prediction from September 2020 to February 2021
Amiranashvili, A. G., Khazaradze, K. R., Japaridze, N. D.
10.1101/2021.04.01.21254448 — Posted: 2021-04-07
Study of the effectiveness of partial quarantines applied to control the spread of the Covid-19 virus
Leon, A.
10.1101/2021.04.03.21254727 — Posted: 2021-04-07
Evolving SARS-CoV-2 variants and mutational cascades
Halley, J. M., Vokou, D., Pappas, G., Sainis, I.
10.1101/2021.04.03.21254871 — Posted: 2021-04-07
Genomic Sequencing of SARS-COV-2 in Rwanda: evolution and regional dynamics
Butera, Y., Mukantwari, E., Artesi, M., Umuringa, J. D., O'Toole, A. N., Hill, V., Rooke, S., Hong, S. L., Dellicour, S., Majyambere, O., Bontems, S., Boujemla, B., Quick, J., Resende, P. C., Loman, N. J., Umumararungu, E., Kabanda, A., Murindahabi, M. M., Tuyisenge, P., Gashegu, M., Rwabihama, J. P., Sindayiheba, R., Gikic, D., Souopgui, J., Ndifon, W., Rutayisire, R., Gatare, S., Mpunga, T., Ngamije, D., Bours, V., Rambaut, A., Nsanzimana, S., Baele, G., Durkin, K., Mutesa, L., Rujeni, N.
10.1101/2021.04.02.21254839 — Posted: 2021-04-07
Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities.
Nigar, S., Shah, S. T., Setu, A. A., Dip, S. D., Ibnat, H., Islam, M. T., Akter, S., Jahid, I. K., Hossain, M. A.
10.1101/2021.04.01.21254770 — Posted: 2021-04-07
Mutations in the B.1.1.7 SARS-CoV-2 spike protein reduce receptor-binding affinity and induce a flexible link to the fusion peptide
Socher, E., Conrad, M., Heger, L., Paulsen, F., Sicht, H., Zunke, F., Arnold, P.
10.1101/2021.04.06.438584 — Posted: 2021-04-06
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity
Park, S. H., Siddiqi, H., Castro, D., De Angelis, A., Oom, A. L., Stoneham, C., Lewinski, M., Clark, A., Croker, B., Carlin, A., Guatelli, J., Opella, S. J.
10.1101/2021.04.06.438579 — Posted: 2021-04-06
Brain Functional Connectivity Scans, Acquired Years Before the Pandemic, Predict COVID-19 Infections in Older Adults: Data From 3,662 Participants
Abdallah, C.
10.1101/2021.04.01.21254709 — Posted: 2021-04-06
Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records
Alamgir, J., Yajima, M., Ergas, R., Chen, X., Hill, N., Munir, N., Saeed, M., Gersing, K., Haendel, M., Chute, C., Abid, R.
10.1101/2021.03.22.21254110 — Posted: 2021-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).